These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33460665)

  • 21. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
    Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
    J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
    Qiu F; Liu L; Lin Y; Yang Z; Qiu F
    Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma.
    An K; Zhang Y; Liu Y; Yan S; Hou Z; Cao M; Liu G; Dong C; Gao J; Liu G
    Oncol Rep; 2020 Sep; 44(3):1116-1126. PubMed ID: 32705225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
    Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
    Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of chemokine (C‑C motif) ligand 5 induced by a novel 8‑hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma.
    Tang JC; Chan D; Chung PY; Liu Y; Lam AK; Law S; Huang W; Chan AS; Lam KH; Zhou Y
    Int J Mol Med; 2024 Dec; 54(6):. PubMed ID: 39364750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p-Hydroxylcinnamaldehyde from cochinchinamomordica seed reverses resistance to TRAIL in human oesophageal squamous cell carcinoma via the activation of the p38 mitogen-activated protein kinase signalling pathway.
    Ma M; Zhang C; Xiang XH; Deng XQ; Dai SL; Wei SS; Zhang XM; Zhao LM; Liu YJ; Shan BE
    Biomed Pharmacother; 2020 Jan; 121():109611. PubMed ID: 31731196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X
    Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.
    Chen Q; Hou J; Wu Z; Zhao J; Ma D
    Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
    Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes.
    Zeng RJ; Zheng CW; Gu JE; Zhang HX; Xie L; Xu LY; Li EM
    Mol Oncol; 2019 Sep; 13(9):2010-2030. PubMed ID: 31314174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
    Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
    Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAPI-1 Exhibits Anti-tumor Efficacy in Human Esophageal Squamous Cell Carcinoma Cells via Suppression of NF-κB Signaling Pathway.
    Gao L; Li L; Zhang D; Qiu J; Qian J; Liu H
    Dig Dis Sci; 2024 Jan; 69(1):81-94. PubMed ID: 38007701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
    Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
    Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
    Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
    Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of RIPK1 and FADD are associated with chemosensitivity and survival in head and heck squamous cell carcinoma via tanshinone IIA-mediated modulation of the RIPK1-FADD-Caspase 8 complex.
    Shen B; Han W; Tan X; Gu KJ; Naseem DF; Zheng G; Li G; Lou J; Chen C
    Mol Carcinog; 2024 Jul; 63(7):1406-1416. PubMed ID: 38695620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.
    Lin WC; Chen LH; Hsieh YC; Yang PW; Lai LC; Chuang EY; Lee JM; Tsai MH
    Carcinogenesis; 2019 Jul; 40(7):883-892. PubMed ID: 30576425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of intratumor heterogeneity of esophageal squamous cell carcinoma on chemotherapy sensitivity].
    Sun L; Wu W; Yan M; Han PL; Zhan X; Ma XW; Cao XG; Zhao S; Gao F; Qi Y; Cao W
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):657-663. PubMed ID: 28926893
    [No Abstract]   [Full Text] [Related]  

  • 38. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
    Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
    Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
    Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
    J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.